NOVOSTE CORP /FL/
10-K405/A, 1998-03-27
MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Previous: RENAISSANCE WORLDWIDE INC, 10-K405, 1998-03-27
Next: DONNA KARAN INTERNATIONAL INC, 10-K405, 1998-03-27




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                Form 10-K/A no.1


|X|   ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
      ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 1996.

|_|   TRANSITION PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF
      1934.

           FOR THE TRANSITION PERIOD _____________ TO ______________.


                         Commission File Number: 0-20727

                               Novoste Corporation
             (Exact Name of Registrant as Specified in Its Charter)

  
                 Florida                                        59-2787476
      (State or Other Jurisdiction of                        (I.R.S. Employer
      Incorporation or Organization)                        Identification No.)

      4350-C International Blvd., Norcross, GA                     30093
      (Address of Principal Executive Offices)                   (Zip Code)

           Registrant's telephone, including area code: (770) 717-0904

        Securities registered pursuant to Section 12(b) of the Act: None

           Securities registered pursuant to Section 12(g) of the Act:

                          Common Stock, $.01 par value
                                (Title of Class)

                       Rights to Purchase Preferred Shares
                                (Title of Class)


Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
requirements for the past 90 days. Yes |X| No |_|

Indicate by check mark if disclosures of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of Registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K |X|.
 
As of February 28, 1997, there were 8,430,375 shares of Common Stock
outstanding. The aggregate market value of voting stock held by non-affiliates
of the Registrant was approximately $67,435,826 based upon the closing sales
price of the Common Stock on February 28, 1997 on the NASDAQ National Market.
Shares of Common Stock held by each officer, director, and holder of five
percent or more of the Common Stock outstanding as of February 28, 1997 have
been excluded in that such persons may be deemed to be affiliates. This
determination of affiliate status is not necessarily conclusive.

                       DOCUMENTS INCORPORATED BY REFERENCE

Certain information is incorporated into Part III of this report by reference to
the Proxy Statement for the Registrant's 1996 annual meeting of stockholders to
be filed with the Securities and Exchange Commission pursuant to Regulation 14A
not later than 120 days after the end of the fiscal year covered by this Form
10-K.
<PAGE>

Form 10-K/A no.1

The Form 10-K for 1996 is hereby amended to reflect the adoption of FAS 128
represented on the attached Financial Data Schedule, Exhibit 27.




                                       2
<PAGE>

                                  SIGNATURE

                             NOVOSTE CORPORATION

Pursuant to the  requirements  of the  Securities  Exchange Act of 1934,  this
Report  has been  signed  below  by the  following  person  on  behalf  of the
Registrant and in the capacity indicated on March 27, 1998.


s/David N. Gill               Vice President-Finance and Chief Financial Officer
- -----------------------       (Principal Financial and Accounting Officer)
David N. Gill                 



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
Restated 1996 Financial Data Schedule
</LEGEND>
<RESTATED>
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              Dec-31-1996
<PERIOD-START>                                 Jan-01-1996
<PERIOD-END>                                   Dec-31-1996
<CASH>                                          19,954,827
<SECURITIES>                                     7,588,693
<RECEIVABLES>                                            0
<ALLOWANCES>                                             0
<INVENTORY>                                              0
<CURRENT-ASSETS>                                27,669,869
<PP&E>                                           1,731,312
<DEPRECIATION>                                   (603,281)
<TOTAL-ASSETS>                                  29,254,938
<CURRENT-LIABILITIES>                              821,121
<BONDS>                                                  0
                                    0
                                              0
<COMMON>                                            82,580
<OTHER-SE>                                      28,351,237
<TOTAL-LIABILITY-AND-EQUITY>                    29,254,938
<SALES>                                                  0
<TOTAL-REVENUES>                                         0
<CGS>                                                    0
<TOTAL-COSTS>                                  (6,802,541)
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                 863,460
<INCOME-PRETAX>                                (5,939,081)
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                            (5,939,081)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                   (5,939,081)
<EPS-PRIMARY>                                       (0.91)
<EPS-DILUTED>                                       (0.91)
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission